Vascular interference: A blockade to tumor epithelial growth

Hepatology

Volumn 39, Issue 6, 2004, Pages 1491-1494

  Crawford, Susan E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CANCER INHIBITION; CELL GROWTH; EDITORIAL; GROWTH REGULATION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER REGENERATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR BLOOD FLOW;

ANIMALS; HUMANS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2542533127     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20278     Document Type: Editorial

References (31)

1. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Hicklin DJ, et al. Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. HEPATOLOGY 2004;39:1517-1524.
2. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003;3:643-651.
3. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenic. Adv Cancer Res 1996;69:135-174
4. Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-676.
5. Li XM, Tang ZY, Qin LX, Zhou J, Sun HC. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 1999;18:511-517.
6. Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res 2003;63:3121-3126.
7. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-844.
8. Falm E. Angiogenesis inhibitors in clinical development: where are we now and where are we going? British J of Cancer 2004;90:1-7.
9. Cleaver O, Melton DA. Endothelial signaling during development. Nat Med 2003;9:661-668.
10. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001;294:559-563.
11. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
12. Musso O, Rehn M, Theret N, Turlin B, Bioulac-Sage P, Lotrian D, et al. Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas. Cancer Res 2001;61:45-49.
13. Schmitz V, Wang L, Barajas M, Gomar C, Prieto J, Qian C. Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice. Gut 2004;53:561-567.
14. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999;285:245-248.
15. Wang L, Schmitz, V, Perez-Mediavilla A, Izal I, Pireto J, Qian C. Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor. Mol Ther 2003;8:72-79.
16. Hayashi K, Kurohiji T, Shirouzu K. Localization of thrombospondin in hepatocellular carcinoma. HEPATOLOGY 1997;25:569-574.
17. Tez M, Tez S. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer 2003;98:1101-1102.
18. Ross MA, Sander CM, Kleeb TB, Watkins SC, Stolz DB. Spatiotemporal expression of angiogenesis growth factors during the revascularization of regeneration rat liver. HEPATOLOGY 2001;34:1135-1148.
19. Greene AK, Wiener S, Puder M, Yoshida A, Shi B, Perez-Atayde AR, et al. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg 2003;237:530-535.
20. Costa RH, Kalinishenko VV, Holterman AX, Wang X. Transcription factors in liver development, differentiation, and regeneration. HEPATOLOGY 2003;38:1331-1347.
21. Furnus CC, Inda AM, Andrini LB, Garcia MN, Carcia AL, Badran AF, Errecalde AL. Chronobiology of the proliferative events related to angiogenesis in mice liver regeneration after partial hepatectomy. Cell Biol Int 2003;27:383-386.
22. Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, et al. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo. Symp Soc Exp Biol 1993;47:227-234.
23. Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, et al. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Diabetologia 2003;46:115-123.
24. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002;21:2000-2008.
25. Theret N, Musso O, Turlin B, Lotrian D, Bioulac-Sage P, Campion JP, et al. Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinoma. HEPATOLOGY 2001;34:82-88.
26. Ng IO, Poon RT, Lee JM, Fan St, Ng M, Tso WK. Microvessel density, vascular endothelial growth factor and its receptor Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol 2001;116:838-845.
27. Horiguchi N, Takayama H, Toyoda M, Otsuka T, Fukusato T, Merlino G, et al. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 2002;21:1791-1799.
28. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role hepatic stellate cells. Semin Liver Dis 2001;21:373-384.
29. Ankoma-Sey V, Wang Y, Dai Z. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. HEPATOLOGY 2000;31:141-148.
30. Olaso E, Salado C, Egilegor E, Gutierrez V, Santisteban A, Sancho-Bru P, et al. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma. HEPATOLOGY 2003;37:674-685.
31. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003;299:890-893.